Ginsenoside Rg1 alleviates ANIT-induced cholestatic liver injury by inhibiting hepatic inflammation and oxidative stress via SIRT1 activation-Reference-Cited by-同舟云学术

Ginsenoside Rg1 alleviates ANIT-induced cholestatic liver injury by inhibiting hepatic inflammation and oxidative stress via SIRT1 activation

Published:2024-01 Issue: Volume:319 Page:117089
ISSN:0378-8741
Container-title:Journal of Ethnopharmacology
language:en
Short-container-title:Journal of Ethnopharmacology

Author:

Gao Qianyan,Li Guodong,Zu Yue,Xu Yanjiao,Wang Congyi,Xiang Dong,He Wenxi,Shang Tianze,Cheng Xinwei,Liu Dong,Zhang Chengliang

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference77 articles.

1. Comparing the efficacy and safety of obeticholic acid and semaglutide in patients with non-alcoholic fatty liver disease: a systematic review;Ahmed;Cureus,2022

2. Ginseng pharmacology: multiple constituents and multiple actions;Attele;Biochem. Pharmacol.,1999

3. New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond;Beuers;J. Hepatol.,2015

4. Fine-tuning of sirtuin 1 expression is essential to protect the liver from cholestatic liver disease;Blokker;Hepatology,2019

5. SIRT1 transgenic mice show phenotypes resembling calorie restriction;Bordone;Aging Cell,2007

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Paeoniflorin inhibited GSDMD to alleviate ANIT-induced cholestasis via pyroptosis signaling pathway;Phytomedicine;2024-11

2. Essential oil from Chimonanthus nitens Oliv. Leaves ameliorate inflammation and oxidative stress in LPS-induced ALI through NF-κB and Nrf2 signaling pathways;Journal of Ethnopharmacology;2024-10

3. Gardenia jasminoides Ellis. Polysaccharides Alleviated Cholestatic Liver Injury by Increasing the Production of Butyric Acid and FXR Activation;Phytotherapy Research;2024-09-05

4. Pirfenidone ameliorates ANIT-induced cholestatic liver injury via modulation of FXR, NF-кB/TNF-α, and Wnt/GSK-3β/β-catenin signaling pathways;Toxicology and Applied Pharmacology;2024-09

5. Kynurenines as a Novel Target for the Treatment of Inflammatory Disorders;Cells;2024-07-26